Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FDV88
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,405
Award facts
- Contract value 100% obligated
- $37,405.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $37,405.16 with a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The parent indefinite delivery vehicle establishes AmerisourceBergen as a prime pharmaceutical vendor with global reach, supplying a comprehensive range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current award for RINVOQ, a prescription medication used in treating rheumatoid arthritis and other inflammatory conditions, demonstrates the contractor's ongoing capability to fulfill targeted pharmaceutical procurement requirements for the federal military health system.
Quick answers
Who was awarded contract SPE2DB26FDV88?
SPE2DB26FDV88 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDV88 worth?
The government has obligated $37,405 on SPE2DB26FDV88.
Is contract SPE2DB26FDV88 an order under another contract?
Yes. SPE2DB26FDV88 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDV88 competed?
The extent of competition for SPE2DB26FDV88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award